I am a
Home I AM A Search Login

Papers of the Week

Papers: 24 Oct 2020 - 30 Oct 2020

Human Studies, Pharmacology/Drug Development


2020 Oct 26

Reg Anesth Pain Med

Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population.


OnabotulinumtoxinA (OBTA) is approved for treating chronic headaches and migraines in adults, but there is limited scientific literature on the outcomes in pediatric patients. The aim of this study was to determine if subjects treated with OBTA reported a statistically significant improvement in the primary features (frequency, intensity, duration and disability scoring) associated with migraines compared with placebo at follow-up visits.